Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Nextnib 20mg Tablet
Manufacturer/Marketed By : CELON LABORATORIES LTD
$14.97 $12.10
Sidmex Inovia offers bulk export supply of Nextnib 20mg Tablet (DASATINIB) for hospitals, distributors and tender buyers. Request a quote with your quantity and destination country.Documents, cold-chain shipping and tenders:...
DASATINIB
Active Pharmaceutical Ingredient
Nextnib 20mg Tablet
$14.97
$12.10
Sidmex Inovia offers bulk export supply of Nextnib 20mg Tablet (DASATINIB) for hospitals, distributors and tender buyers. Request a quote with your quantity and destination country.
Documents, cold-chain shipping and tenders: see our Export FAQ.
Priority markets: Philippines, United Arab Emirates, Kenya, Egypt, Brazil. We also export worldwide, including:
Middle East: United Arab Emirates, Saudi Arabia, Oman, Qatar, Kuwait, Bahrain, Iraq, Jordan, Lebanon, Yemen, Turkey
Africa: Egypt, Algeria, Morocco, Libya, Nigeria, Ghana, Benin, Burkina Faso, Côte d'Ivoire, Gambia, Kenya, Tanzania, Rwanda, Ethiopia, Djibouti, Somalia, South Africa, Zimbabwe, Mauritius
Asia: Sri Lanka, Bangladesh, Nepal, Maldives, Philippines, Vietnam, Laos, Malaysia, Thailand, Singapore, Taiwan
CIS & Eastern Europe: Russia, Kazakhstan, Uzbekistan, Azerbaijan, Georgia, Serbia, Latvia
Latin America & Caribbean: Mexico, Brazil, Chile, Peru, Colombia, Bolivia, Dominican Republic, Bahamas, Barbados
Europe & Other: Switzerland, United Kingdom, Canada
Related products we supply: Nextnib 50mg Tablet
Nextnib 20mg tablet consists of the active ingredient Dasatinib, which explains the Nextnib 20mg composition. It is prescribed for adults and children above one year of age for the treatment of Chronic Myeloid Leukemia, making Nextnib 20mg for leukemia an important targeted therapy option. This medicine is used in newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia in the chronic phase, as well as Ph+ acute lymphoblastic leukemia in patients who have not responded well to other treatments. Chronic Myeloid Leukemia is a blood cancer caused by changes in the Philadelphia chromosome that lead to uncontrolled production of white blood cells. Acute lymphoblastic leukemia, more common in children, involves rapid multiplication of abnormal lymphocytes that crowd out healthy cells. For adult patients, the Nextnib 20mg dosage for adults is decided by the treating oncologist based on disease stage, prior treatments, and tolerance. Some patients and clinicians also compare treatment options, leading to discussions such as Nextnib 20mg vs Dasanat 20mg, which are evaluated based on response, side-effect profile, and clinical guidance rather than cost alone. The common side effects associated with Nextnib 20mg include diarrhoea, headache, cough, rash, nausea, tiredness, vomiting, muscle pain, weakness, low appetite, and changes in blood pressure. If these symptoms persist or become bothersome, medical advice should be sought. Patient feedback shared as Nextnib 20 mg reviews often highlights the importance of regular monitoring and early reporting of side effects to maintain treatment continuity.
Active Pharmaceutical Ingredient
Uses
• Children and adults with chronic myeloid leukemia.
• Adults with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) with resistance to prior therapy.
Benefits
Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Nextnib 20mg side effects are
Most Common Side Effects
• Diarrhea
• Headache
• Cough
• Rash
• Nausea, tiredness, vomiting
• Muscle pain, weakness
• Low appetite
• High or low BP
Common Side Effects
• Unusual bleeding or bruising
• Rapid heart rate
• Changes in consciousness or speech
• Breathlessness and swelling all over the body
• Fever or signs of infection
• Fluid retention
• Heart problems
• Myelosuppression
• Severe allergic reaction
How To Use
Take the tablet with or without food at the same time each day. Do not break, crush or chew the tablet. Your doctor will decide the dose and frequency of administration of Nextnib 20mg tablet based on your disease severity and other factors. Do not stop taking the tablet without consulting your healthcare professional.
Safety Advice
• Breast Feeding: It is not recommended to breastfeed while taking Nextnib 20mg tablet as it is not known whether this medication passes into breast milk. You should not breastfeed during treatment and for 2 weeks after your final dose.
• Alcohol: It is not known whether it is safe to consume alcohol with Nextnib 20mg tablet. Consult your doctor for advice.
• Liver: Inform your physician before starting this treatment if you have liver diseases. Your physician will prescribe a dose accordingly.
• Lungs: It is unknown whether Nextnib 20mg is safe to administer in patients with lung problems. Inform your physician if you have any lung disease before starting the treatment.
• Driving: Avoid driving or using machinery if you experience symptoms like breathlessness or altered consciousness.
• Pregnancy: Nextnib 20mg tablet is not recommended to use during pregnancy unless clearly necessary. Your physician will discuss the potential risk during pregnancy. Women should use effective birth control during treatment and 30 days after the final dose.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.